Rhythm Pharmaceuticals (RYTM) Cash from Operations Growth (1y) (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) Cash from Operations Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 356.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn | -9.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.50% |
| Dec 31, 2025 | -34.73% |
| Sep 30, 2025 | -5.58% |
| Jun 30, 2025 | 19.82% |
| Mar 31, 2025 | 0.96% |
| Dec 31, 2024 | 35.86% |
| Sep 30, 2024 | 13.80% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | -11.83% |
| Dec 31, 2023 | 13.58% |
| Sep 30, 2023 | 37.75% |
| Jun 30, 2023 | -5.88% |
| Mar 31, 2023 | 32.07% |
| Dec 31, 2022 | 15.99% |
| Sep 30, 2022 | -17.00% |
| Jun 30, 2022 | -21.89% |
| Mar 31, 2022 | -59.95% |
| Dec 31, 2021 | -38.97% |
| Sep 30, 2021 | -48.57% |
| Jun 30, 2021 | -7.10% |